The mechanisms of this association are worth to be investigated as NSAIDs and aspirin was proven to protect against the risk of gastric cancer by a different cyclooxygenase 2 mediated pathway [33–35] in order to determine genetic factors that can be used to identified candidates for preventive therapy. The gene discussed is PTGS2; the disease is gastric cancer.